We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+19.88%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$4.69B
AUM Growth
+$740M
Cap. Flow
+$156M
Cap. Flow %
3.32%
Top 10 Hldgs %
56.21%
Holding
579
New
130
Increased
106
Reduced
151
Closed
187

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.71%
2 Technology 19.77%
3 Healthcare 12.09%
4 Communication Services 8.07%
5 Consumer Staples 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
376
Petrobras
PBR
$121B
$251K 0.01%
+18,150
New +$221K
IMXI icon
377
International Money Express
IMXI
$428M
$246K 0.01%
+10,024
New +$246K
CF icon
378
CF Industries
CF
$19.6B
$239K 0.01%
3,439
-12,407
-78% -$865K
ADBE icon
379
Adobe
ADBE
$110B
$237K 0.01%
484
-1,634
-77% -$658K
PCRX icon
380
Pacira BioSciences
PCRX
$985M
$233K 0.01%
+5,823
New +$241K
HCC icon
381
Warrior Met Coal
HCC
$5.7B
$231K ﹤0.01%
5,932
+34
+0.6% +$1.23K
QDEL icon
382
QuidelOrtho
QDEL
$985M
$229K ﹤0.01%
2,760
-695
-20% -$60.8K
UNFI icon
383
United Natural Foods
UNFI
$2.91B
$226K ﹤0.01%
11,549
+3,249
+39% +$81.6K
COLL icon
384
Collegium Pharmaceutical
COLL
$864M
$224K ﹤0.01%
10,401
-895
-8% -$20.3K
SUPN icon
385
Supernus Pharmaceuticals
SUPN
$2.65B
$223K ﹤0.01%
7,409
-997
-12% -$34.9K
TROX icon
386
Tronox
TROX
$858M
$221K ﹤0.01%
+17,374
New +$218K
O icon
387
Realty Income
O
$59.6B
$221K ﹤0.01%
+3,692
New +$225K
DVA icon
388
DaVita
DVA
$11.1B
$219K ﹤0.01%
2,181
-832
-28% -$77.2K
DSGX icon
389
Descartes Systems
DSGX
$6.79B
$211K ﹤0.01%
+2,634
New +$205K
CHKP icon
390
Check Point Software Technologies
CHKP
$13.3B
$207K ﹤0.01%
+1,647
New +$207K
TSEM icon
391
Tower Semiconductor
TSEM
$24.2B
$206K ﹤0.01%
5,482
-1,906
-26% -$78.8K
JWSM.WS
392
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$31.3K ﹤0.01%
624,998
AA icon
393
Alcoa
AA
$13.2B
-7,404
Closed -$315K
AAPL icon
394
Apple
AAPL
$4.55T
-1,871
Closed -$309K
ABT icon
395
Abbott
ABT
$202B
-18,902
Closed -$1.91M
ACI icon
396
Albertsons Companies
ACI
$6.14B
-19,397
Closed -$403K
ADNT icon
397
Adient
ADNT
$1.48B
-10,907
Closed -$447K
ADT icon
398
ADT
ADT
$5.44B
-116,926
Closed -$845K
AEP icon
399
American Electric Power
AEP
$65.8B
-2,563
Closed -$233K
AIG icon
400
American International
AIG
$40.5B
-10,022
Closed -$505K

Similar funds

Lee Ainslie's Q2 2023 Portfolio in Review

As of Q2 2023, Lee Ainslie held 579 positions worth $4.69B, up 19% from $3.95B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Lee Ainslie deployed $156M of net new capital in Q2 2023, opening 130 new positions and adding to 106 existing holdings. Its largest new stake was Constellation Brands: 592,121 shares worth $146M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 41% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Salesforce, an estimated $91.7M trimmed.

  • Lee Ainslie's largest Q2 2023 buy was Constellation Brands: 592,121 shares worth $146M.
  • Lee Ainslie added most to Coupang in Q2 2023, an estimated $85.7M increase.
  • Lee Ainslie's biggest Q2 2023 reduction was Salesforce, cutting an estimated $91.7M.
  • Lee Ainslie fully exited CATALENT, INC. in Q2 2023, selling an estimated $69.4M.
  • Lee Ainslie's ten largest holdings make up 56% of its $4.69B portfolio in Q2 2023.
  • Lee Ainslie opened 130 new positions and closed 187 in Q2 2023.
  • Lee Ainslie's portfolio value rose 19% quarter-over-quarter to $4.69B.

Based on Maverick Capital's 13F filing for Q2 2023, filed 14 Aug 2023.